Tunkel R S, Lachmann E
Memorial Sloan-Kettering Cancer Center, New York, USA.
Postgrad Med. 1998 Oct;104(4):131-4, 137-8, 141 passim. doi: 10.3810/pgm.1998.10.450.
In developed countries, prevalence is increasing of malignancy-related secondary lymphedema, usually resulting from lymph node resection or irradiation. Untreated lymphedema usually increases over time, and the physical and psychological sequelae in even mild cases demand appropriate diagnosis and treatment. Patients should be referred to a clinic familiar with the treatment of lymphedema, and therapy should be customized to optimize patient compliance. Treatment programs do exist, but clinicians who are unfamiliar with them may find it difficult to determine the best program for individual patients. Currently, most lymphedema clinics favor the use of MLT-CPT for significant lymphedema.
在发达国家，与恶性肿瘤相关的继发性淋巴水肿的患病率正在上升，通常是由淋巴结切除或放疗引起的。未经治疗的淋巴水肿通常会随着时间的推移而加重，即使是轻度病例的身心后遗症也需要进行适当的诊断和治疗。患者应转诊至熟悉淋巴水肿治疗的诊所，治疗方案应量身定制，以提高患者的依从性。治疗方案确实存在，但不熟悉这些方案的临床医生可能难以确定适合个体患者的最佳方案。目前，大多数淋巴水肿诊所倾向于对严重淋巴水肿使用手法淋巴引流-加压治疗（MLT-CPT）。
